Why the study?
Does ADP-beta-S act as a partial agonist on human platelets compared to ADP?
Does ADP-beta-S act as a partial agonist on human platelets compared to ADP?
ADP-beta-S acts as a partial agonist on human platelets, inducing aggregation and inhibiting adenylate cyclase but with less potency than ADP.
Answers are grounded in this paper and cite their sources.
ADP-beta-S partial agonism at platelet receptors may inform P2Y pharmacology; leaves open human translation from animal data.
1 The effects of an adenosine diphosphate (ADP) analogue, adenosine 5'-O-(2-thiodiphosphate) (ADP-beta-S), in which a terminal phosphate oxygen has been replaced by sulphur, were studied on human platelets. 2 ADP-beta-S induced platelet aggregation and inhibited prostaglandin E1 (PGE1)-stimulated adenylate cyclase but in both cases was less potent than ADP and did not achieve the same maximal effects. 3 Both actions of ADP could be inhibited by the simultaneous addition of ADP-beta-S (50 microM). 4 Aggregation induced by 11 alpha, 9 alpha-epoxymethano prostaglandin H2 (a stable endoperoxide analogue) was not inhibited by simultaneous addition of ADP-beta-S (50 microM). 5 The behaviour of ADP-beta-S towards human platelets was consistent with it being a partial agonist.
No takes yet. Share an insight, caveat, or question.
Cusack et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: